GRAIL Inc GRAL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)
-
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
-
GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
-
GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update
-
Wheels Up Announces Gregory Summe to Join Board of Directors
-
GRAIL to Announce Second Quarter 2024 Financial Results
-
GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population
-
GRAIL Advances the Galleri® Registrational Clinical Trial Program
Trading Information
- Previous Close Price
- $14.40
- Day Range
- $13.64–14.50
- 52-Week Range
- $12.51–23.36
- Bid/Ask
- $13.30 / $14.25
- Market Cap
- $427.24 Mil
- Volume/Avg
- 722,898 / 1.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.07
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.grail.com
Comparables
Valuation
|
Metric
|
GRAL
|
TIHE
|
PSNL
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 0.17 | — | 2.47 |
Price/Sales | 4.07 | — | 3.28 |
Price/Cash Flow | — | — | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
GRAL
|
TIHE
|
PSNL
|
|---|---|---|---|
Quick Ratio | 11.09 | 0.00 | 2.93 |
Current Ratio | 11.55 | 0.00 | 3.31 |
Interest Coverage | — | — | −2,072.48 |
Quick Ratio
GRAL
TIHE
PSNL
Profitability
|
Metric
|
GRAL
|
TIHE
|
PSNL
|
|---|---|---|---|
Return on Assets (Normalized) | −11.72% | — | −29.69% |
Return on Equity (Normalized) | −13.53% | — | −46.55% |
Return on Invested Capital (Normalized) | −13.47% | — | −37.04% |
Return on Assets
GRAL
TIHE
PSNL
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Rcjdxtxf | Jrncb | $234.7 Bil | |||
| Danaher Corp
DHR
| Swrqrwdlr | Lsgbx | $198.9 Bil | |||
| IQVIA Holdings Inc
IQV
| Njjspjwvl | Yjskdj | $42.8 Bil | |||
| Agilent Technologies Inc
A
| Nzntbjkctt | Vctzt | $42.5 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Qjpmrbwrl | Jmmcv | $42.1 Bil | |||
| Mettler-Toledo International Inc
MTD
| Sbkrgqzfkr | Yddny | $31.4 Bil | |||
| Icon PLC
ICLR
| Xvyhknnwf | Wzdzfnp | $23.7 Bil | |||
| Waters Corp
WAT
| Dmllmkfbt | Cvgwv | $21.2 Bil | |||
| Illumina Inc
ILMN
| Bsctgqff | Kyrhr | $20.7 Bil | |||
| Labcorp Holdings Inc
LH
| Bfgwphdvp | Dnphb | $18.6 Bil |
United States